Shareholder Votes

LifeStance Health Group, Inc. shareholders approved Election of Class II Directors at the 2026-06-02 meeting.

“Proposal 1: Election of Directors The stockholders of the Company elected the director nominees listed below to serve on the Company’s Board of Directors as members of Class II for a term of three years. The results of the vote were as follows: Name of Nominee For Withhold Broker Non-Votes David Bourdon 244,968,319 83,966,052 29,782,714 Robert Bessler 280,015,618 48,918,753 29,782,714”

CRISPR Therapeutics AG shareholders approved Non-Binding Advisory Vote on the 2025 Compensation Report (under Swiss statutory compensation report) at the 2026-06-04 meeting.

“The endorsement of the 2025 Compensation Report was approved on a non-binding basis. The results of the non-binding vote were as follows: FOR AGAINST ABSTAIN BROKER NON-VOTES NUMBER 39,906,651 8,704,469 143,733 22,498,855”

CRISPR Therapeutics AG shareholders approved Re-election of Members of the Compensation Committee at the 2026-06-04 meeting.

“Ali Behbahani, M.D., H. Edward Fleming, Jr., M.D., John T. Greene and Briggs W. Morrison, M.D. were each duly re-elected as members of the Company’s Compensation Committee of the Board of Directors. The results of the election were as follows: NOMINEE FOR AGAINST ABSTAIN BROKER NON-VOTES Ali Behbahani, M.D. 35,458,908 13,198,641 97,304 22,498,855 H. Edward Fleming Jr., M.D. 46,322,476 2,341,513 90,864 22,498,855 John T. Greene 46,319,646 2,326,146 109,061 22,498,855 Briggs W. Morrison, M.D. 45,317,635 3,329,265 107,953 22,498,855”

CRISPR Therapeutics AG shareholders approved Re-election of Members to the Board of Directors and the Chairman at the 2026-06-04 meeting.

“Samarth Kulkarni, Ph.D., Ali Behbahani, M.D., Maria Fardis, Ph.D., H. Edward Fleming Jr., M.D., Simeon J. George, M.D., John T. Greene, Katherine A. High, M.D., Sandesh Mahatme, LL.M., Briggs W. Morrison, M.D., Christian Rommel, Ph.D. and Douglas A. Treco, Ph.D. were each duly re-elected as members of the Company’s Board of Directors and Samarth Kulkarni, Ph.D. was duly re-elected as the chairman of the Company’s Board of Directors. The results of the election were as follows: NOMINEE FOR AGAINST ABSTAIN BROKER NON-VOTES Samarth Kulkarni, Ph.D. 47,043,987 1,628,226 82,640 22,498,855 Ali Behbahani, M.D. 35,498,392 13,174,523 81,938 22,498,855 Maria Fardis, Ph.D. 47,804,457 874,207 76,189 22,498,855 H. Edward Fleming Jr., M.D. 46,977,636 1,686,127 91,090 22,498,855 Simeon J. George, M.D. 47,435,748 1,225,519 93,586 22,498,855 John T. Greene 46,876,367 1,793,109 85,377 22,498,855 Katherine A. High, M.D. 47,779,619 899,787 75,447 22,498,855 Sandesh Mahatme, LL.M. 46,268,964 2,405,580 80,30”

CRISPR Therapeutics AG shareholders approved Discharge of the Members of the Company's Board of Directors and Executive Committee at the 2026-06-04 meeting.

“The discharge of the members of the Company's Board of Directors and the Executive Committee from personal liability for their activities during the year ended December 31, 2025 was approved. The results of the vote were as follows: FOR AGAINST ABSTAIN BROKER NON-VOTES NUMBER 48,379,678 262,761 112,414 22,498,855”

CRISPR Therapeutics AG shareholders approved Approval of the Appropriation of Financial Results at the 2026-06-04 meeting.

“The proposal to carry forward the net loss resulting from the appropriation of financial results was approved. The results of the vote were as follows: FOR AGAINST ABSTAIN BROKER NON-VOTES NUMBER 70,554,606 415,599 283,503 0”

CRISPR Therapeutics AG shareholders approved Approval of the Swiss Management Report, the Consolidated Financial Statements and the Statutory Financial Statements of the Company for the Year Ended December 31, 2025 at the 2026-06-04 meeting.

“The Swiss management report, the consolidated financial statements and the statutory financial statements of the Company for the year ended December 31, 2025 were approved. The results of the vote were as follows: FOR AGAINST ABSTAIN BROKER NON-VOTES NUMBER 70,716,663 288,652 248,393 0”

Cricut, Inc. shareholders approved Proposal to ratify the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-03 meeting.

“Proposal to ratify the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. 800,970,919 326,657 123,518 0”

Cricut, Inc. shareholders approved Proposal to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as described in the proxy statement. at the 2026-06-03 meeting.

“Proposal to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as described in the proxy statement. 760,620,738 11,873,058 71,944 28,855,354”

Cricut, Inc. shareholders approved Election of seven directors at the 2026-06-03 meeting.

“Cricut Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (“Annual Meeting”) on June 3, 2026. At its Annual Meeting, the Company elected the following seven individuals to its Board of Directors (the “Board”). Each director will serve for the ensuing year and until his or her successor is duly elected and qualified.”

Neurogene Inc. shareholders approved An advisory, non-binding vote on whether future non-binding advisory votes on the compensation paid by the Company to its named executive officers should be held every one, two or three years at the 2026-06-03 meeting.

“An advisory, non-binding vote on whether future non-binding advisory votes on the compensation paid by the Company to its named executive officers should be held every one, two or three years: One Year Two Years Three Years Shares Abstaining Broker Non-Votes 10,006,265 3,407 16,721 63,077 1,297,937”

Neurogene Inc. shareholders approved Ratification on an advisory (non-binding) basis of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-03 meeting.

“Ratification on an advisory (non-binding) basis of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026: Shares For Shares Against Shares Abstaining 9,345,925 1,939,039 102,443”

Neurogene Inc. shareholders approved Approval on an advisory (non-binding) basis of the compensation of the Company’s named executive officers at the 2026-06-03 meeting.

“Approval on an advisory (non-binding) basis of the compensation of the Company’s named executive officers: Shares For Shares Against Shares Abstaining Broker Non-Votes 9,991,445 36,394 61,631 1,297,937”

Neurogene Inc. shareholders approved Election of two Class III directors, Robert Baffi and Rohan Palekar at the 2026-06-03 meeting.

“Election of two Class III directors, Robert Baffi and Rohan Palekar, each to serve until the 2029 annual meeting of stockholders and until their respective successors are elected and qualified: Nominee Shares For Shares Withheld Broker Non-Votes Robert Baffi 9,540,734 548,736 1,297,937 Rohan Palekar 10,058,331 31,139 1,293,937”

Abacus Global Management, Inc. shareholders approved Advisory Vote on the frequency of the Say-on-Pay Vote at the 2026-06-03 meeting.

“Proposal No. 5 - Advisory Vote on the frequency of the Say-on-Pay Vote The Company’s stockholders approved the advisory vote for a one-year frequency for the Company to seek a Say-on-Pay vote on executive compensation with the following votes: FREQUENCY FOR ABSTAIN 1 Year 52,503,249 2,281,921 2 Years 54,412 2,281,921 3 Years 18,117,425 2,281,921”

Abacus Global Management, Inc. shareholders approved Advisory vote on Executive Compensation at the 2026-06-03 meeting.

“Proposal No. 4 - Advisory vote on Executive Compensation The Company’s stockholders approved the advisory vote on executive compensation with the following votes: FOR AGAINST ABSTAIN BROKER NON-VOTES 62,263,261 8,351,613 2,342,133 5,216,556”

Abacus Global Management, Inc. shareholders approved Approval of the Abacus Global Management, Inc. 2026 Long-Term Equity Incentive Plan (the '2026 LTIP') at the 2026-06-03 meeting.

“Proposal No. 3 - Approval of the Abacus Global Management, Inc. 2026 Long-Term Equity Incentive Plan (the “2026 LTIP”) The Company’s stockholders approved the 2026 LTIP with the following votes: FOR AGAINST ABSTAIN BROKER NON-VOTES 62,076,844 8,532,200 2,347,963 5,216,556”

Abacus Global Management, Inc. shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2026-06-03 meeting.

“Proposal No. 2 - Ratification of Independent Registered Public Accounting Firm The Company’s stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 with the following votes: FOR AGAINST ABSTAIN 78,073,928 33,924 65,711”

Abacus Global Management, Inc. shareholders approved Election of Directors at the 2026-06-03 meeting.

“Proposal No. 1 - Election of Directors The following nominees were re-elected to serve as Class III directors of the Company for a three-year term with the following votes: NOMINEE FOR WITHHOLD BROKER NON-VOTES Jay Jackson 72,107,921 849,086 5,216,566 Thomas W. Corbett, Jr. 67,618,868 5,338,139 5,216,556”

LEGALZOOM.COM, INC. shareholders approved Advisory vote on compensation of named executive officers at the 2026-06-03 meeting.

“Proposal 3 – The advisory vote on the compensation of the Company’s named executive officers was approved as set forth below: FOR AGAINST ABSTAIN BROKER NON-VOTES 130,993,487 4,292,140 51,638 25,073,628”

LEGALZOOM.COM, INC. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-03 meeting.

“Proposal 2 – The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 was ratified as set forth below: FOR AGAINST ABSTAIN BROKER NON-VOTES 158,422,344 1,968,220 20,330 —”

LEGALZOOM.COM, INC. shareholders approved Election of one director nominee as a Class II director at the 2026-06-03 meeting.

“Proposal 1 – The one director nominee named in the proxy statement was elected as a Class II director to serve for a three-year term and until her successor has been duly elected and qualified, or until her earlier death, resignation, removal, retirement or disqualification as set forth below: DIRECTOR NOMINEE FOR WITHHOLD BROKER NON-VOTES Sivan Whiteley 107,724,702 27,612,563 25,073,628”

WEBTOON Entertainment Inc. shareholders approved Ratification of selection of Samil PricewaterhouseCoopers as independent registered public accounting firm at the 2026-06-03 meeting.

“Proposal 3 - Ratification of the Selection of Independent Registered Public Accounting Firm The stockholders ratified the selection by the Audit Committee of the Board of Directors of the Company of Samil PricewaterhouseCoopers as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The voting results were as follows: Votes For Votes Against Votes Abstain 128,182,191 5,223 1,947”

WEBTOON Entertainment Inc. shareholders approved Advisory vote on the compensation of named executive officers at the 2026-06-03 meeting.

“Proposal 2 - Advisory Vote on the Compensation of Our Named Executive Officers The stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers. The voting results were as follows: Votes For Votes Against Votes Abstain Broker Non-Votes 127,064,456 46,916 2,150 1,075,839”

WEBTOON Entertainment Inc. shareholders approved Election of three Class II directors at the 2026-06-03 meeting.

“Proposal 1 - Election of Directors The stockholders elected each of the three nominees named below as Class II directors to serve until the 2029 Annual Meeting and until their successors are duly elected and qualified. The voting results were as follows: Nominee Votes For Votes Withheld Broker Non-Votes Namsun Kim 114,966,850 12,146,672 1,075,839 Jun Masuda 113,666,847 13,446,675 1,075,839 Isabelle Winkles 126,835,509 278,013 1,075,839”

Academy Sports & Outdoors, Inc. shareholders approved Advisory vote on fiscal year 2025 compensation paid to named executive officers at the 2026-06-04 meeting.

“Say-on-Pay 56,136,547 533,746 45,561 4,056,313”

Academy Sports & Outdoors, Inc. shareholders approved Ratification of Deloitte & Touche LLP as Independent Registered Public Accounting Firm at the 2026-06-04 meeting.

“Auditor Ratification 59,714,421 1,025,028 32,718”

Academy Sports & Outdoors, Inc. shareholders approved Election of Class III Directors at the 2026-06-04 meeting.

“Election of Class III Directors Votes For Votes Withheld Broker Non-Votes Ken Hicks 56,212,506 503,348 4,056,313 Beryl Raff 56,390,582 325,272 4,056,313 Jeff Tweedy 56,416,017 299,837 4,056,313”

GPGI, Inc. shareholders approved Reincorporation of the Company from Delaware to Nevada by conversion at the 2026-06-04 meeting.

“At the Special Meeting, the Reincorporation Proposal was approved. The vote with respect to the Reincorporation Proposal was as follows: Votes For % For Votes Against % Against Abstain 171,505,308 59.2% 96,295,425 33.2% 147,411”

Ivanhoe Electric Inc. shareholders approved Ratification of Deloitte LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-04 meeting.

“Ratification of Deloitte LLP 142,509,114 56,042 25,635”

Ivanhoe Electric Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-04 meeting.

“Advisory Vote on Executive Compensation 126,520,556 1,754,587 41,949 14,273,699”

Ivanhoe Electric Inc. shareholders approved Election of nine directors to serve until the next annual meeting at the 2026-06-04 meeting.

“Election of Directors Robert Friedland 125,673,086 2,617,780 26,226 14,273,699 Taylor Melvin 127,960,176 336,379 20,537 14,273,699 Russell Ball 124,898,265 3,397,893 20,934 14,273,699 Sofia Bianchi 115,242,059 13,056,085 18,948 14,273,699 Hirofumi Katase 127,807,067 488,621 21,404 14,273,699 Patrick Loftus-Hills 127,877,438 418,430 21,224 14,273,699 Victoire de Margerie 128,035,699 253,063 28,330 14,273,699 Priya Patil 102,804,957 25,486,966 25,169 14,273,699 Ronald Vance 127,346,067 950,007 21,018 14,273,699”

Baldwin Insurance Group, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-04 meeting.

“The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved. The voting results on this proposal were as follows: For Against Abstain 109,549,914 62,128 50,867”

Baldwin Insurance Group, Inc. shareholders approved Advisory vote on the compensation of the Company’s named executive officers at the 2026-06-04 meeting.

“The shareholders voted to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as described in the Proxy Statement. The voting results on this proposal were as follows: For Against Abstain Broker Non-Votes 94,240,293 4,125,200 786,956 10,510,460”

Baldwin Insurance Group, Inc. shareholders approved Election of Directors at the 2026-06-04 meeting.

“The following nominees were elected to the Company’s Board of Directors as Class I Directors, each to serve until the annual shareholders’ meeting to be held in 2029 or until his or her successor is elected and qualified. The voting results for each nominee were as follows: Nominee For Withheld Broker Non-Votes Lowry Baldwin 94,869,684 4,282,765 10,510,460 Sathish Muthukrishnan 98,197,244 955,205 10,510,460 Sunita Parasuraman 98,076,188 1,076,261 10,510,460 Ellyn Shook 81,501,294 17,651,155 10,510,460”

SEACOR Marine Holdings Inc. shareholders approved Ratification of Appointment of Grant Thornton LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026 at the 2026-06-02 meeting.

“Proposal No. 3 – Ratification of Appointment of Grant Thornton LLP as the Company ’ s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026 Votes For Votes Against Abstain Broker Non-Votes 21,260,381.59 94,949.00 100.00 0.00”

SEACOR Marine Holdings Inc. shareholders approved Advisory Vote to Approve the Company's Named Executive Officer Compensation at the 2026-06-02 meeting.

“Proposal No. 2 – Advisory Vote to Approve the Company ’ s Named Executive Officer Compensation Votes For Votes Against Abstain Broker Non-Votes 13,314,887.69 339,632.85 28,216.82 7,672,693.23”

SEACOR Marine Holdings Inc. shareholders approved Election of Directors at the 2026-06-02 meeting.

“Proposal No. 1 – Election of Directors Director Name Votes For Votes Withheld Broker Non-Votes Andrew R. Morse 13,249,782.37 432,955.00 7,672,693.23 John Gellert 13,656,993.37 25,744.00 7,672,693.23 Alfredo Miguel Bejos 13,241,975.37 440,762.00 7,672,693.23 Julie Persily 13,232,446.37 450,291.00 7,672,693.23 R. Christopher Regan 13,216,691.37 466,046.00 7,672,693.23 Lisa P. Young 13,235,161.37 447,576.00 7,672,693.23”

ABERCROMBIE & FITCH CO /DE/ shareholders approved Ratify the Appointment of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending January 30, 2027 at the 2026-06-03 meeting.

“Proposal 3 – Ratify the Appointment of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending January 30, 2027 Votes For Votes Against Abstentions Broker Non-Votes 39,593,508 1,740,606 16,525 —”

ABERCROMBIE & FITCH CO /DE/ shareholders approved Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers for the Fiscal Year Ended January 31, 2026 at the 2026-06-03 meeting.

“Proposal 2 – Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers for the Fiscal Year Ended January 31, 2026 (“Say on Pay”) Votes For Votes Against Abstentions Broker Non-Votes 37,441,578 851,288 33,272 3,024,501”

ABERCROMBIE & FITCH CO /DE/ shareholders approved Elect the Nine Director Nominees Named in the Proxy Statement to Serve Until the 2027 Annual Meeting of Stockholders at the 2026-06-03 meeting.

“Proposal 1 – Elect the Nine Director Nominees Named in the Proxy Statement to Serve Until the 2027 Annual Meeting of Stockholders Votes For Votes Against Abstentions Broker Non-Votes Kerrii B. Anderson 37,742,958 559,242 23,938 3,024,501 Andrew Clarke 38,276,302 29,727 20,109 3,024,501 Susie Coulter 38,276,514 25,556 24,068 3,024,501 James A. Goldman 37,976,045 329,340 20,753 3,024,501 Fran Horowitz 38,281,561 24,673 19,904 3,024,501 Helen E. McCluskey 38,276,569 29,087 20,482 3,024,501 Arturo Nuñez 38,279,236 26,350 20,552 3,024,501 Kenneth B. Robinson 38,278,611 27,115 20,412 3,024,501 Nigel Travis 38,271,706 33,487 20,945 3,024,501”

Vita Coco Company, Inc. shareholders approved Advisory vote on executive compensation. at the 2026-06-03 meeting.

“Item 3 – Advisory vote on executive compensation.”

Vita Coco Company, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-03 meeting.

“Item 2 – Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Vita Coco Company, Inc. shareholders approved Election of three Class II directors for a term of office expiring on the date of the annual meeting of stockholders in 2029. at the 2026-06-03 meeting.

“On June 3, 2026, The Vita Coco Company, Inc. (the “Company”) held its Annual Meeting of Stockholders.”

Medicus Pharma Ltd. shareholders approved Shareholders approved the special resolution authorizing the Board, in its discretion, to effect a consolidation of the Company's common shares, no par value (the "Common Shares") on the basis of a consolidation ratio to be determined by the Board, up to a maximum ratio of 50 pre-consolidation Commo at the 2026-06-03 meeting.

“Shareholders approved the special resolution authorizing the Board, in its discretion, to effect a consolidation of the Company's common shares, no par value (the "Common Shares") on the basis of a consolidation ratio to be determined by the Board, up to a maximum ratio of 50 pre-consolidation Common Shares for every one post-consolidation Common Share, if the Board determines such a consolidation is necessary or desirable, including, without limitation, for the purpose of meeting any applicable stock exchange or regulatory requirements. Shareholder approval of this Proposal 3 required the affirmative vote of at least two-thirds of the votes cast by the shareholders present at the Meeting in person or by proxy: For Against Abstain Broker Non-Votes 26,729,776 2,335,461 N/A 1”

Medicus Pharma Ltd. shareholders approved Shareholders elected all nine of the directors nominated by the Board to serve for one-year terms, until our 2027 annual meeting of shareholders or until their successors are duly elected or appointed, unless they resign, are removed, or become disqualified in accordance with the Articles of Incorpo at the 2026-06-03 meeting.

“Shareholders elected all nine of the directors nominated by the Board to serve for one-year terms, until our 2027 annual meeting of shareholders or until their successors are duly elected or appointed, unless they resign, are removed, or become disqualified in accordance with the Articles of Incorporation of the Company (the "Articles") or the Business Corporations Act (Ontario): Name For Withhold Abstain Broker Non-Votes William L. Ashton 15,181,189 354,284 N/A 13,529,765 Dr. Raza Bokhari 15,068,465 467,008 N/A 13,529,765 Robert J. Ciaruffoli 15,186,431 349,042 N/A 13,529,765 Barry Fishman 15,189,646 345,827 N/A 13,529,765 Dr. Larry Kaiser 15,198,014 337,459 N/A 13,529,765 Patrick Mahaffy 15,193,804 341,669 N/A 13,529,765 Dr. Sara R. May 15,192,642 342,831 N/A 13,529,765 Hon. Cathy McMorris Rodgers 15,178,833 356,640 N/A 13,529,765 Ajay Raju 15,190,298 345,175 N/A 13,529,765”

Medicus Pharma Ltd. shareholders approved Shareholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the Company's 2026 fiscal year and the authorization of the Company's board of directors to fix the auditors' remuneration and terms of engagement at the 2026-06-03 meeting.

“Shareholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the Company's 2026 fiscal year and the authorization of the Company's board of directors (the "Board") to fix the auditors' remuneration and terms of engagement: For Withhold Abstain Broker Non-Votes 28,308,860 756,378 N/A 0”

BLUE OWL CAPITAL INC. shareholders approved Ratification of Appointment of KPMG LLP as Independent Registered Public Accounting Firm for 2026 Fiscal Year at the 2026-06-04 meeting.

“The proposal to ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the Company’s 2026 fiscal year was approved based on the following votes: FOR AGAINST ABSTAIN 6,073,218,752 980,718 516,886”

BLUE OWL CAPITAL INC. shareholders approved Election of Class II Directors at the 2026-06-04 meeting.

“The nominees listed below were elected as Class II directors of the Company to serve for three-year terms expiring at the 2029 Annual Meeting of Stockholders once their respective successors have been duly elected and qualified or until their earlier resignation or removal, based on the following votes: FOR AGAINST ABSTAIN BROKER NON-VOTES Claudia Holz 5,762,013,618 182,494,922 173,156 130,034,660 Marc S. Lipschultz 5,796,875,813 147,628,704 177,179 130,034,660 Michael D. Rees 5,797,152,129 147,345,212 184,355 130,034,660”

PennyMac Financial Services, Inc. shareholders approved Approval, by non-binding vote, of the Company's executive compensation. at the 2026-06-03 meeting.

“Proposal 3: Approval, by non-binding vote, of the Company’s executive compensation. Votes For Votes Against Abstentions Broker Non-Votes 41,064,673 1,453,740 229,612 4,799,772”